Factor IX polypeptide formulations
US11642398B2 · kind B2 · utility
2Cited by
242References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 27, 2020 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Sep 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.